ACE is a key player in aberrant RAS activity as evidenced by studies wherein pre-stroke ACE inhibition reduced ischemic stroke incidence [120] and severity [57], and improved poststroke recovery (BI at discharge) [116]. This evidence concerns the gene ACE and stroke disorder.